1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
PetVivo Holdings, Inc.

PetVivo Holdings, Inc.

PETV
PetVivo Holdings, Inc.US flagOther OTC
0.68
USD
+0.00
- -
25.56MMarket Cap
PetVivo Holdings, Inc.
PETV
(Other OTC)

Recent

price

0.68

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
- -
- -
- -
- -
0.04
- -
- -
- -
- -
- -
0.01
0.09
0.07
0.06
0.04
0.04
Revenue per Share
-5.86
-2
-1.55
- -
-0.91
-2.07
-7.71
-0.61
-1.03
-0.39
-0.57
-0.57
-0.85
-0.78
-0.41
-0.36
-0.31
Basic EPS, GAAP
-3.83
-0.96
-1.27
- -
-0.44
-0.39
-0.09
-0.16
-0.18
-0.11
-0.15
-0.5
-0.71
-0.55
-0.29
-0.2
-0.17
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.46
-3.46
-2.19
-0.18
0.09
-0.04
-6.43
0.03
-0.17
-0.18
-0.13
0.6
0.07
0.04
0.17
0.06
0.04
Book Value per Share
-1.46
-3.46
-2.19
-0.26
-0.19
-9.37
-7.32
-0.27
-0.29
-0.19
-0.14
0.59
0.06
0.04
0.09
0.03
0.01
Tangible Book Value per Share
- -
- -
- -
- -
2
2
2
4
5
5
6
9
10
14
20
30
33
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
-4,334.91
-230,062.51
-151,345.5
- -
-56,190.97
-15,574.72
-4,374.69
-952.23
-1,096.45
-711.3
-706.28
-662.4
Operating Margin (%)
- -
- -
- -
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
1
1
Depreciation Expense
- -
- -
- -
- -
-2
-4
-16
-2
-5
-2
-4
-5
-9
-11
-8
-10
-10
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
-4,868.99
-218,017.03
-154,790.6
- -
-58,047.21
-28,007.47
-4,338.76
-950.5
-1,130.92
-741.63
-917.45
-827.34
Profit Margin (%)
- -
- -
- -
- -
- -
-1
-1
-1
-1
-1
-1
6
- -
- -
1
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
LT Debt
- -
- -
- -
- -
- -
15
1
- -
-1
-1
-1
6
1
1
4
2
1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-259.77
-1,552.87
-343.02
-339.61
-405.06
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
36
38
Market Capitalization
39
25
32

Working Capital

FRC

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
1
2
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-128.04%
-78.7%
-47.87%
Free Cash Flow
66.24%
84.54%
3.9%
Net Income, GAAP
50.01%
28.65%
24.7%
Sales/Revenue/Turnover
- -
307.15%
0.8%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
1
- -
1
2026
- -
- -
- -
- -
1
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.11
-0.11
-0.09
- -
-0.41
2026
-0.1
-0.11
-0.07
- -
-0.36
2027
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
electroCore, Inc. (ECOR)
MedX Health Corp (MDXHF)
Sonendo, Inc. (SONX)
Lifecare AS (LIFE.OL)
Stryker Corporation (SYK)
BIOLASE, Inc. (BIOL)
Business
PetVivo Holdings, Inc. (OTCQX: PETV) is a veterinary biotech and biomedical device company that manufactures, commercializes, and licenses innovative medical devices and therapeutics for companion animals, primarily targeting lameness, joint pain, and osteoarthritis in dogs and horses. The company offers Spryng with OsteoCushion Technology, an intra-articular injectable veterinary medical device composed of proprietary biocompatible protein-based biomaterials including collagen, elastin, and glycosaminoglycans that mimic natural cartilage to restore joint mechanics and promote tissue repair; it maintains a robust pipeline of 18 additional therapeutic devices for veterinary and human applications protected by 19 patents and 8 pending applications. PetVivo operates through its wholly owned subsidiary Gel-Del Technologies, Inc., serving veterinary practices in the United States with distribution channels focused on animal health; founded in 2009 and headquartered at 5151 Edina Industrial Blvd, Suite 575, Edina, Minnesota 55439, the company leverages human medical technologies adapted for pets in the $11 billion companion animal market. Recent developments include non-exclusive wholesale distribution partnerships entered in December 2024 with Vedco, Inc. and Clipper Distributing, LLC to enhance product access for veterinarians; termination of prior agreements with MWI Animal Health and Covetrus North America in March 2025 and February 2025, respectively, to diversify sales channels; a vendor partner agreement in October 2025 with Veterinary Growth Partners for expanded therapeutics access; launch of PetVivo AI, Inc. platform in November 2025 reducing veterinary client acquisition costs by 50-90%; an exclusive 10-year licensing agreement with Digital Landia for the AgenticPet AI framework; closure of note conversion agreements in September 2025 extinguishing over $2 million in debt; a distribution agreement in September 2025 with Nupsala Limited; uplisting to OTCQX Best Market in July 2025; and fiscal Q2 2026 revenues up 50% reported in November 2025.

Company News

Company News APIChatGPT

  • globenewswire.com

    PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION

  • seekingalpha.com

    PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript

  • globenewswire.com

    PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

  • globenewswire.com

    PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET

  • globenewswire.com

    PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM

  • globenewswire.com

    PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM

  • globenewswire.com

    PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

  • seekingalpha.com

    PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript

  • globenewswire.com

    PetVivo Reports Financial and Operational Results for Fiscal 2026

  • globenewswire.com

    PetVivo Reports Financial and Operational Results for Fiscal 2026

  • globenewswire.com

    PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

  • globenewswire.com

    PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

  • globenewswire.com

    PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform

  • seekingalpha.com

    PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript

  • globenewswire.com

    PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th

  • globenewswire.com

    PetVivo Holdings, Inc. to Host Virtual Investor Event

  • globenewswire.com

    PetVivo Holdings, Inc. to Host Virtual Investor Event

  • defenseworld.net

    PetVivo (NASDAQ:PETV) Trading 2.5% Higher – Time to Buy?

  • newsfilecorp.com

    PetVivo Holdings, Inc. to Present at the Market Movers Investor Summit

  • defenseworld.net

    PetVivo (NASDAQ:PETV) Trading Down 11% – Should You Sell?